Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Hemosol to begin multinational phase III trials of Hemolink

March 15, 1999

FDA grants priority review status, sets date for advisory committee review of Actos

March 15, 1999

Long-term treatment with phen-fen associated with valvular abnormalities

March 15, 1999

FDA okays new indication and minimal liver function testing for Lescol

March 12, 1999

Health Canada approves Viagra

March 11, 1999

Greater reductions in LDL cholesterol lead to fewer cardiac events

March 11, 1999

FDA approves new therapy for type II diabetes

March 10, 1999

Series from Lilly especially useful for hypercholesterolemia in postmenopausal women

March 10, 1999

New patent strengthens Millennium's position on UCPH

March 9, 1999

Rhone-Poulenc Rorer claims series for diabetes and diabetic complications

March 9, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...